|
|
|
|
  |
| NOTICES |
|
| Notice No. |
|
20220421-32 |
|
Notice Date |
|
21 Apr 2022 |
|
| Category |
|
Trading |
|
Segment |
|
Derivatives |
|
| Subject |
|
Exclusion of Futures and Options contracts of 2 Securities from Equity Derivatives Segment |
|
|
|
|
|
| Content |
|
|
This is with reference to SEBI circular No. SEBI/HO/MRD/DP/CIR/P/2018/67 dated April 11, 2018, regarding stock selection/exclusion criteria.
Trading Members are requested to note that based on the eligibility criteria prescribed in above circulars, contracts for new expiry months for below mentioned security shall not be available for trading in Equity Derivatives segment on expiry of existing contract months.
|
Sr. No.
|
Security Name
|
Derivatives Asset Code
|
Equity Scrip Code
|
|
1
|
ALEMBIC PHARMACEUTICALS LTD
|
APLD
|
533573
|
|
2
|
STRIDES PHARMA SCIENCE LTD
|
STAR
|
532531
|
It may be also noted that the existing unexpired contracts of expiry months April 2022, May 2022 and June 2022 shall be available for trading till their respective expiry and new strikes shall also be introduced in the existing contract months.
Members are requested to note that there shall be no contracts available for trading in the above mentioned security with effect from July 01, 2022.
|
For & on behalf of BSE Ltd,
|
|
|
|
|
|
Ketan Jantre
|
Sandeep Pujari
|
|
Sr. GM – Trading Operations
|
DGM – Trading Operations
|
|
|